BioMérieux S.A.
BIM
株式のランク
#1763
bioMérieux S.A. is a global entity operating across the Americas, Europe, the... bioMérieux S.A. is a global entity operating across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, specializing in the development and production of in vitro diagnostic solutions. The company's sophisticated systems utilize biological samples to identify infectious diseases, cardiovascular conditions, and various forms of cancer. Additionally, bioMérieux provides essential microbiological testing services for the manufacturing sectors, primarily serving the food, pharmaceutical, cosmetics, and veterinary industries. Its client base includes clinical and hospital laboratories, medical practitioners, blood banks, and industrial quality control facilities. Founded in 1963, originally under the name B-D Mérieux, bioMérieux S.A. maintains its headquarters in Marcy l'Etoile, France, and functions as a subsidiary of Institut Mérieux SA.
株価
$103.91
時価総額
$12.23B
変化（1日）
0.86%
変化（1年）
-19.74%
国
FR
取引 BioMérieux S.A. (BIM)
カテゴリー
Healthcare
BioMérieux S.A.（BIM）の配当利回りの履歴
BioMérieux S.A.（銘柄コード: BIM）の配当利回り（TTM）は2023-12-31時点で0.84%です。
過去5年間の平均配当利回り: 0.64%
過去5年間の平均配当利回り: 0.64%
BioMérieux S.A.（BIM）の2005から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
| 年 | 配当利回り | 変化 |
|---|---|---|
| 2026 (TTM) | 1.14% | 39.02% |
| 2024 | 0.82% | -2.38% |
| 2023 | 0.84% | -4.55% |
| 2022 | 0.88% | 79.59% |
| 2021 | 0.49% | 188.24% |
| 2020 | 0.17% | -61.36% |
| 2019 | 0.44% | -25.42% |
| 2018 | 0.59% | 31.11% |
| 2017 | 0.45% | -36.62% |
| 2016 | 0.71% | -21.98% |
| 2015 | 0.91% | -22.22% |
| 2014 | 1.17% | -8.59% |
| 2013 | 1.28% | -5.88% |
| 2012 | 1.36% | -23.60% |
| 2011 | 1.78% | 42.40% |
| 2010 | 1.25% | 26.26% |
| 2009 | 0.99% | -21.43% |
| 2008 | 1.26% | 31.25% |
| 2007 | 0.96% | 7.87% |
| 2006 | 0.89% | -1.11% |
| 2005 | 0.90% | 0.00% |
類似企業または競合他社の配当利回り（TTM）
| 企業 | 配当利回り | 国 |
|---|---|---|
| 0.27% |
US
|
|
| 0.68% |
US
|
|
| 0.00% |
US
|
|
| 0.00% |
CN
|
|
| 0.59% |
US
|
